Jazz Pharmaceuticals
VYXEOS
Manufacturer:
Jazz Pharmaceuticals
Name:
VYXEOS
HCPCS Code Descriptor:
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Category:
J Code
HCPCS:
J9153
NDC(s):
68727-0745-01, 68727-0745-02
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
VYXEOS is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9153 is aligned to the drug VYXEOS.